Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 8,876–8,900 of 27,380 studies, newest first · page 356 of 1096.

May 2022 25

  1. 2022-05-11

    Association of the top 20 Alzheimer's disease risk genes with [18F]flortaucipir PET

    ✓ Peer-reviewed Brain scans and imaging Alzheimer's & dementia (Amsterdam, Netherlands)

    Key finding: APOE ε4 showed significant (P < .05) associations with tau deposition across all disease stages. +3 more findings

  2. 2022-05-11

    Role of Environmental Toxicants on Neurodegenerative Disorders

    ✓ Peer-reviewed Risk factors Frontiers in toxicology

    Key finding: Besides, solvent exposure is also a significant contributor to neurological diseases.

  3. 2022-05-11

    Diagnostic value of serum versus plasma phospho-tau for Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Alzheimer's research & therapy

    Key finding: Comparable diagnostic performances and strong correlations between serum versus plasma pairs suggest that p-tau analyses can be expanded to research cohorts and hospital systems that prefer serum to other blood matrices. +4 more findings

  4. 2022-05-11

    Commentary: Aducanumab-Related ARIA: Paean or Lament?

    ✓ Peer-reviewed Drug development Clinical nuclear medicine

    Key finding: Høilund-Carlsen and colleagues raise important issues related to amyloid PET, diagnosis of Alzheimer disease, and recently approved antiamyloid treatment aducanumab.

  5. 2022-05-10

    Interprofessional collaboration in palliative dementia care through the eyes of informal caregivers

    ✓ Peer-reviewed Health systems and care delivery Dementia (London, England)

    Key finding: Our study revealed that intrinsic and extrinsic factors and interprofessional collaboration among healthcare professionals affected informal caregivers' collaborative roles. +1 more finding

  6. 2022-05-10

    Area Deprivation Index and Gut-Brain Axis in Cirrhosis

    ✓ Peer-reviewed Risk factors Clinical and Translational Gastroenterology

    Key finding: A total of 321 people with cirrhosis (60 years, 78% men, 75% non-Hispanic White, 24% non-Hispanic African American, 4% Hispanic) were included. 45% had prior HE and 56% MHE. +4 more findings

  7. 2022-05-10

    Association of life course adiposity with risk of incident dementia: a prospective cohort study of 322,336 participants

    ✓ Peer-reviewed Long-term cohort studies Molecular psychiatry

    Key finding: Furthermore, evidence on fat distribution and body composition measures are scarce and few studies estimated the association between early life adiposity and dementia risk. +3 more findings

  8. 2022-05-10

    Increasing the Cognitive Screening Efficiency of Global Phase III Trials in Early Alzheimer Disease: The Cognitive Task Force

    ✓ Peer-reviewed Drug development Alzheimer disease and associated disorders

    Key finding: A Cognitive Task Force (CTF) was established for the MissionAD program with the aim of reducing the screen failure (SF) rate to ∼30% and thereby reduce unnecessary subject burden, site burden, and excess trial costs. +3 more findings

  9. 2022-05-09

    Deep learning-based brain age prediction in normal aging and dementia

    ✓ Peer-reviewed Digital health tools Nature aging

    Key finding: Occlusion analysis, performed to facilitate the interpretation of the model, revealed that the model learns an age- and modality-specific pattern of brain aging.

  10. 2022-05-08

    Perceived social isolation is correlated with brain structure and cognitive trajectory in Alzheimer's disease

    ✓ Peer-reviewed Risk factors GeroScience

    Key finding: Both objective and perceived social isolations were associated with future cognitive decline and increase risk of Alzheimer's disease (AD). +4 more findings

  11. 2022-05-07

    Adherence to the Mediterranean diet and incident frailty: Results from a longitudinal study

    ✓ Peer-reviewed Prevention and risk Maturitas

    Key finding: 176 and 131 participants developed incident frailty, as measured with the FI and TFI respectively. +4 more findings

  12. 2022-05-07

    Evaluation of four gamma-based methods for calculating confidence intervals for age-adjusted mortality rates when data are sparse

    ✓ Peer-reviewed Risk factors Population Health Metrics

    Key finding: The three modifications had comparable performance when the number of deaths was large relative to the denominator and the age distribution was as in the standard population. +4 more findings

  13. 2022-05-07

    Sex differences in the association between cardiovascular diseases and dementia subtypes: a prospective analysis of 464,616 UK Biobank participants

    ✓ Peer-reviewed Long-term cohort studies Biology of sex differences

    Key finding: Whether the association of cardiovascular diseases (CVDs) with dementia differs by sex remains unclear, and the role of socioeconomic, lifestyle, genetic, and medical factors in their association is unknown. +3 more findings

  14. 2022-05-06

    α-synuclein as an emerging pathophysiological biomarker of Alzheimer's disease

    ✓ Peer-reviewed Brain tissue and pathology Expert review of molecular diagnostics

    Key finding: α-syn aggregates represent the pathological hallmark of synucleinopathies as well as a frequent copathology (almost 1/3 of cases) in AD. +4 more findings

  15. 2022-05-06

    Obesity as a Risk Factor for Dementia and Alzheimer's Disease: The Role of Leptin

    ✓ Peer-reviewed Prevention and risk International journal of molecular sciences

    Key finding: In this review, we discuss different leptin resistance mechanisms that could be implicated in increasing the risk of developing AD, as leptin resistance is frequently associated with obesity, which is a chronic low-grade inflammatory state, and obesity is considered a risk factor for AD.

  16. 2022-05-05

    Targeting endothelial ion signalling to rescue cerebral blood flow in cerebral disorders

    ✓ Peer-reviewed Vascular contributions Vascular pharmacology

    Key finding: The mechanism whereby an increase in neuronal activity (NA) leads to a local elevation in cerebral blood flow to supply the active neurons with oxygen and nutrients and remove the catabolic waste has been termed neurovascular coupling (NVC). +4 more findings

  17. 2022-05-05
  18. 2022-05-05

    Delusional Severity Is Associated with Abnormal Texture in FLAIR MRI

    ✓ Peer-reviewed Tau biomarkers Brain sciences

    Key finding: Biomarkers were extracted from a total of 42 participants with longitudinal time points representing 164 imaging volumes. +4 more findings

  19. 2022-05-04

    Alzheimer's disease drug development pipeline: 2022

    ✓ Peer-reviewed Drug development Alzheimer's & dementia (New York, N. Y.)

    Key finding: The AD drug development pipeline has agents representing a substantial array of treatment mechanisms and targets.

  20. 2022-05-03

    Principal components from untargeted cerebrospinal fluid metabolomics associated with Alzheimer's disease biomarkers

    ✓ Peer-reviewed Biomarkers Neurobiology of aging

    Key finding: Significant PCs were further tested with other CSF NeuroToolKit (NTK) and imaging biomarkers. +3 more findings

  21. 2022-05-03

    Phospho-specific plasma p-tau181 assay detects clinical as well as asymptomatic Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Annals of clinical and translational neurology

    Key finding: The novel plasma p-tau181 and p-tau231 assays did not show cross-reactivity. +4 more findings

  22. 2022-05-03

    Area Deprivation Index and Progression to Dementia (S2.007)

    ✓ Peer-reviewed Risk factors Neurology

    Key finding: To investigate the association of the area deprivation index (ADI), as assigned at the census block group-level, with progression to dementia in cognitively unimpaired at baseline participants (≥50 years old) of the population-based Mayo Clinic Study of Aging (MCSA).

  23. 2022-05-03

    Alzheimer's Disease Plasma Biomarkers Distinguish Clinical Diagnostic Groups in Memory Clinic Patients

    ✓ Peer-reviewed Biomarkers Dementia and geriatric cognitive disorders

    Key finding: Several recent research studies show high performance of blood biomarkers to identify Alzheimer's disease also in the pre-dementia mild cognitive impairment (MCI) stage, but data from the routine clinical care memory clinic setting are needed.

  24. 2022-05-02

    Sleep, Pain, and Neurodegeneration: A Mendelian Randomization Study

    ✓ Peer-reviewed Risk factors Frontiers in neurology

    Key finding: We observed suggestive evidence of risky effects of CHR on AMD (P = 0.0034), SS on AD (P = 0.0044), and INS on ALS (P = 0.0123). +1 more finding

  25. 2022-05-02

    Multimer Detection System-Oligomerized Amyloid Beta (MDS-OAβ): A Plasma-Based Biomarker Differentiates Alzheimer's Disease from Other Etiologies of Dementia

    ✓ Peer-reviewed Biomarkers International journal of Alzheimer's disease

    Key finding: MDS-OAβ level was not significantly different between AD and mixed AD-VaD, but both groups were significantly different from the NCI/SCI and from the non-AD group.

Browse the library by subject, with the full score breakdown →